Jupiter Asset Management LTD Uni Qure N.V. Transaction History

Jupiter Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$18.12 - $27.32 $990,094 - $1.49 Million	-54,641 Reduced 39.12%	85,044 $1.93 Million
Q3 2022 Nov 10, 2022	SELL	$16.98 - $25.54 $1.28 Million - $1.93 Million	-75,394 Reduced 35.05%	139,685 $2.62 Million
Q2 2022 Aug 10, 2022	BUY	$13.15 - $20.45 $2.83 Million - $4.4 Million	215,079 New	215,079 $4.01 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.